Schonfeld Strategic Advisors LLC Genetron Holdings LTD Transaction History

Schonfeld Strategic Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.91 - $1.23 $31,577 - $42,681	-34,700 Reduced 18.68%	151,093 $158,000
Q4 2022 Feb 14, 2023	BUY	$0.8 - $1.12 $20,575 - $28,805	25,719 Added 16.07%	185,793 $208,000
Q3 2022 Nov 14, 2022	BUY	$0.91 - $1.69 $15,393 - $28,588	16,916 Added 11.82%	160,074 $125,000
Q2 2022 Aug 15, 2022	BUY	$1.28 - $2.4 $183,242 - $343,579	143,158 New	143,158 $243,000
Q3 2021 Nov 16, 2021	SELL	$11.55 - $20.3 $1.14 Million - $2 Million	-98,631 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.9 - $23.29 $1.12 Million - $1.45 Million	-62,327 Reduced 38.72%	98,631 $1.99 Million
Q1 2021 May 17, 2021	SELL	$13.71 - $30.64 $4.04 Million - $9.02 Million	-294,523 Reduced 64.66%	160,958 $3.45 Million
Q4 2020 Feb 16, 2021	SELL	$9.31 - $14.0 $4.6 Million - $6.91 Million	-493,834 Reduced 52.02%	455,481 $6.38 Million
Q3 2020 Nov 16, 2020	SELL	$9.1 - $15.81 $4.47 Million - $7.76 Million	-490,970 Reduced 34.09%	949,315 $11,000
Q2 2020 Aug 14, 2020	BUY	$11.29 - $16.0 $16.3 Million - $23 Million	1,440,285 New	1,440,285 $17.4 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.